Nonintubated Acute Respiratory Distress Syndrome (ARDS)

Respiratory
1
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
1
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Akebia Therapeutics
Akebia TherapeuticsCAMBRIDGE, MA
1 program
1
Vadadustat 900mgPhase 2/31 trial
Active Trials
NCT07086755RecruitingEst. Jul 2026

Trial Timeline

Clinical trial activity over time

2025
2026
Akebia TherapeuticsVadadustat 900mg

Clinical Trials (1)

Vadadustat for the Treatment of Nonintubated Acute Respiratory Distress Syndrome Due to Pathogen-Associated Lung Injury

Start: Oct 2025Est. completion: Jul 2026
Phase 2/3Recruiting

Related Jobs in Respiratory

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials
1 companies competing in this space